About: A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate (en) A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate (nl)
skos:prefLabel	A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate (en) A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate (nl)
name	A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate (en) A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate (nl)
title	wds:Q65356365-6E15DF73-B00A-4F67-9F48-7D113573CF14
title	A Randomized, Double-blind, Placebo-controlled, Phase 2 Study To Assess The Immune Response Following Administration Of Zoster Vaccine To Subjects With Rheumatoid Arthritis Receiving Tofacitinib (Cp-690,550) Or Placebo With Background Methotrexate Treatment (en)
end time	wds:Q65356365-28ECBC0B-0B5A-4788-BB4C-5E36D33492D3
end time	2015-06-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q65356365-46663A62-BDB2-4C28-9EDD-F2DB5CC1506B
instance of	clinical trial
start time	wds:Q65356365-DC3FEAB1-6EE7-45D5-84D3-A27C1B86CB9C
start time	2014-06-01 00:00:00Z (xsd:dateTime)
country	wds:Q65356365-1F4984A9-2A42-4343-B43C-81960E60D5BF
country	United States of America
research site	wds:Q65356365-3807C7B9-3BC6-4766-B056-391C5AFB3078 wds:Q65356365-4A65DC08-A22C-4EA7-8D2D-833DB81E6C3C wds:Q65356365-4AD8C8BD-4469-4CAB-8DCC-95E47AFCE35E wds:Q65356365-D4629DB2-2E5B-4EA0-B475-B009BB2FE847
research site	University of California, Los Angeles Dartmouth University Altoona Center for Clinical Research Palmetto Clinical Trial Services
minimum age	wds:Q65356365-E2A53C59-A612-42A4-B411-B94F555730B9
minimum age	50 (xsd:decimal)
medical condition	wds:Q65356365-E96B75E1-BE3F-4236-A9AA-1A9A12562B5B
medical condition	arthritis
number of participants	wds:Q65356365-50AF8DED-4EF8-481F-A77E-8510C96E308C
number of participants	112 (xsd:decimal)
study type	wds:Q65356365-D52D94D8-6C38-4972-8D21-5394348DB006
study type	interventional study
ClinicalTrials.gov ID	wds:Q65356365-C1A0D653-7062-4793-A7B6-1949E7BA4264
ClinicalTrials.gov ID	NCT02147587
clinical trial phase	wds:Q65356365-33D3969D-9FCB-4613-A473-885194C231EE
clinical trial phase	phase II clinical trial
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q65356365

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software